These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6004862)

  • 1. Experimental observations on flufenamic, mefenamic, and meclofenamic acids. I. Pharmacology.
    Winder CV
    Ann Phys Med; 1966; Suppl():7-16. PubMed ID: 6004862
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of non-steroidal anti-inflammatory drugs in the Evans Blue pleural effusion.
    Sancilio LF; Rodriguez R
    Proc Soc Exp Biol Med; 1966 Dec; 123(3):707-10. PubMed ID: 5959007
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of the fenamates on the threshold of pain.
    Haward LR
    Ann Phys Med; 1966; Suppl():55-7. PubMed ID: 4895007
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-inflammatory properties of N-phenylanthranilic acid derivatives in relation to uncoupling of oxidative phosphorylation.
    Saeki K; Muraoka S; Yamasaki H
    Jpn J Pharmacol; 1972 Apr; 22(2):187-99. PubMed ID: 4262661
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical properties of anti-inflammatory drugs. X. The inhibition of serotonin formation in vitro and inhibition of the esterase activity of alpha-chymyotrypsin.
    Skidmore IF; Whitehouse MW
    Biochem Pharmacol; 1967 May; 16(5):737-51. PubMed ID: 6036725
    [No Abstract]   [Full Text] [Related]  

  • 6. Physicochemical properties and uncoupling activity of 3'-substituted analogues of N-phenylanthranilic acid.
    Terada H; Muraoka S
    Mol Pharmacol; 1972 Jan; 8(1):95-103. PubMed ID: 5061521
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological studies of a new antiinflammatory compound, 2-phenyl-6-dimethylamino-6H-cycloheptoxazole.
    Kobayashi S; Takagi H
    Arzneimittelforschung; 1968 Oct; 18(10):1352-4. PubMed ID: 4387784
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacology of antirheumatic drugs].
    Domenjoz R
    Verh Dtsch Ges Rheumatol; 1969; 1():343-61. PubMed ID: 4253979
    [No Abstract]   [Full Text] [Related]  

  • 9. The fibrinolytic activity of anti-inflammatory drugs.
    Gryglewski R
    J Pharm Pharmacol; 1966 Jul; 18(7):474. PubMed ID: 4381731
    [No Abstract]   [Full Text] [Related]  

  • 10. Concerning the regulation of some diverse biochemical reactions underlying the inflammatory response by salicylic acid, phenylbutazone and other acidic antirheumatic drugs.
    Skidmore IF; Whitehouse MW
    J Pharm Pharmacol; 1966 Aug; 18(8):558-60. PubMed ID: 4381870
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological studies on niflumic acid, with special reference to the comparison with fenametes. 1. Anti-inflammatory and analgesic actions].
    Tsurumi K; Nozaki M; Hayashi M; Yamaguchi A; Hiramatsu Y
    Nihon Yakurigaku Zasshi; 1972 Nov; 68(6):668-82. PubMed ID: 4676611
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the antiviral activity in vitro of some non-steroidal anti-inflammatory drugs.
    Inglot AD
    J Gen Virol; 1969 Mar; 4(2):203-14. PubMed ID: 4306296
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of mefenamic acid and flufenamic acid on plasma uric acid levels.
    Latham BA; Radcliff F; Robinson RG
    Ann Phys Med; 1966 Aug; 8(7):242-3. PubMed ID: 5918265
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological properties of a series of derivatives of mefenamic and flufenamic acids].
    Linari G; Spanò R
    Farmaco Sci; 1971 Apr; 26(4):303-11. PubMed ID: 5559990
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental observations on flufenamic, mefanamic and meclofenamic acids. II. Toxicology in animals.
    Kaump DH
    Ann Phys Med; 1966; Suppl():16-23. PubMed ID: 4979051
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological and toxicological testing of new anti-inflammatory agent azapropazon=3-dimethylamine-7-methyl-1,2-(n-propylmalonyl)-1,2-dihydro-1,2,4-benzotriazine].
    Jahn U; Adrian RW
    Arzneimittelforschung; 1969 Jan; 19(1):36-52. PubMed ID: 5819362
    [No Abstract]   [Full Text] [Related]  

  • 17. ANTI-INFLAMMATORY AND ANTIPYRETIC PROPERTIES OF N-(2,6-DICHLORO-M-TOLYL)ANTHRANILIC ACID (CI-583).
    WINDER CV; WAX J; WELFORD M
    J Pharmacol Exp Ther; 1965 Jun; 148():422-9. PubMed ID: 14334278
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological studies of N-benzoyl-N'-phenyl-2,6-diaminobenzoic acid (F1). 3. Interaction with proteins].
    Fujimura H; Tsurumi K; Abe A; Hayashi M; Nakano K
    Nihon Yakurigaku Zasshi; 1973 Nov; 69(6):918-29. PubMed ID: 4799521
    [No Abstract]   [Full Text] [Related]  

  • 19. A method for differentiating nonspecific irritants from anti-inflammatory agents using the carrageenin abscess test.
    Goldstein S; DeMeo R; Shemano I; Beiler JM
    Proc Soc Exp Biol Med; 1966 Dec; 123(3):712-5. PubMed ID: 5959009
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the mechanism of action of salicylates. VII. Effect of a few anti-inflammatory agents on uridine-5'-diphosphoglucose dehydrogenase.
    Lee KH; Spencer MR
    J Pharm Sci; 1969 Sep; 58(9):1152-5. PubMed ID: 4310286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.